Quick Answer
BioCorRx Inc. reported Operating Income Loss of -$4.83 million for the year ending 2025.
- BioCorRx Inc. showed an increase of +5.7% in Operating Income Loss from 2024 to 2025.
- This data is from BioCorRx Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2014 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2014 to 2025), BioCorRx Inc.'s Operating Income Loss has declined by 58.3%.
- Historical annual values: Fiscal year 2025: -$4.83 million | Fiscal year 2024: -$5.12 million | Fiscal year 2023: -$3.79 million | Fiscal year 2022: -$4.70 million | Fiscal year 2021: -$5.51 million | Fiscal year 2020: -$7.49 million | Fiscal year 2019: -$5.56 million | Fiscal year 2018: -$4.63 million | Fiscal year 2017: -$2.89 million | Fiscal year 2016: -$2.18 million | Fiscal year 2015: -$5.12 million | Fiscal year 2014: -$3.05 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: